FDA Panel Will Discuss Regulatory Plan For Future COVID-19 Boosters

By Beth Wang / March 21, 2022 at 4:53 PM
FDA’s vaccine advisers will meet April 6 to discuss the regulatory framework for future COVID-19 booster shots, including the process for selecting different strains for coronavirus vaccines to address current and emerging variants, the agency announced Monday (March 21). The advisory committee will not discuss or vote on any specific product applications, the agency said. The agency, its vaccine advisory committee, and representatives from the Centers for Disease Control and Prevention and the National Institutes of Health will discuss what...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.